These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evidence-based medicine as it applies to acid suppression in the hospitalized patient. Cash BD Crit Care Med; 2002 Jun; 30(6 Suppl):S373-8. PubMed ID: 12072665 [TBL] [Abstract][Full Text] [Related]
5. Treatment of nonvariceal upper gastrointestinal bleeding. Rivkin K; Lyakhovetskiy A Am J Health Syst Pharm; 2005 Jun; 62(11):1159-70. PubMed ID: 15914876 [TBL] [Abstract][Full Text] [Related]
6. Acid suppression in critically ill patients: what does the evidence support? Spirt MJ Pharmacotherapy; 2003 Oct; 23(10 Pt 2):87S-93S. PubMed ID: 14587963 [TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494 [TBL] [Abstract][Full Text] [Related]
8. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding. Howden CW Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression. Fennerty MB Crit Care Med; 2002 Jun; 30(6 Suppl):S351-5. PubMed ID: 12072660 [TBL] [Abstract][Full Text] [Related]
11. Successful Endoscopic Hemostasis Is a Protective Factor for Rebleeding and Mortality in Patients with Nonvariceal Upper Gastrointestinal Bleeding. Han YJ; Cha JM; Park JH; Jeon JW; Shin HP; Joo KR; Lee JI Dig Dis Sci; 2016 Jul; 61(7):2011-8. PubMed ID: 26923946 [TBL] [Abstract][Full Text] [Related]
12. The role of intravenous proton pump inhibitors in the modern management of nonvariceal upper gastrointestinal bleeding. Barkun AN Drugs Today (Barc); 2003 Mar; 39 Suppl A():3-10. PubMed ID: 12712215 [TBL] [Abstract][Full Text] [Related]
13. Controlled trial of medical therapy for active upper gastrointestinal bleeding and prevention of rebleeding. Zuckerman G; Welch R; Douglas A; Troxell R; Cohen S; Lorber S; Melnyk C; Bliss C; Christiansen P; Kern F Am J Med; 1984 Mar; 76(3):361-6. PubMed ID: 6367452 [TBL] [Abstract][Full Text] [Related]
15. Review article: the role of antisecretory therapy in the management of non-variceal upper gastrointestinal bleeding. Triadafilopoulos G Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():53-8. PubMed ID: 16303038 [TBL] [Abstract][Full Text] [Related]
16. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers. Sakurada T; Kawashima J; Ariyama S; Kani K; Takabayashi H; Ohno S; Kato S; Yakabi K Dig Endosc; 2012 Mar; 24(2):93-9. PubMed ID: 22348833 [TBL] [Abstract][Full Text] [Related]
19. The role of proton pump inhibitors in the management of upper gastrointestinal bleeding. Leontiadis GI; Howden CW Gastroenterol Clin North Am; 2009 Jun; 38(2):199-213. PubMed ID: 19446254 [TBL] [Abstract][Full Text] [Related]
20. Multidisciplinary management strategies for acute non-variceal upper gastrointestinal bleeding. Lu Y; Loffroy R; Lau JY; Barkun A Br J Surg; 2014 Jan; 101(1):e34-50. PubMed ID: 24277160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]